|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.940 USD | +0.76% |
|
-7.24% | -31.85% |
| 07-07 | ARS Pharmaceuticals, Inc. Announces Appointment of Donn Casale as Director, Effective July 7, 2026 | CI |
| 07-07 | ARS Pharmaceuticals, Inc. Announces CEO Changes | CI |
| Market Cap | 788M 690M 636M 588M 1.11B 75.2B 1.13B 7.6B 2.98B 37.05B 2.96B 2.9B 127B | P/E 2026 * |
-4.46x | P/E 2027 * | -8.25x |
|---|---|---|---|---|---|
| Enterprise Value | 788M 690M 636M 588M 1.11B 75.2B 1.13B 7.6B 2.98B 37.05B 2.96B 2.9B 127B | EV / Sales 2026 * |
5.64x | EV / Sales 2027 * | 3.21x |
| Free-Float |
83.79% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: ARS Pharmaceuticals, Inc.
| 1 day | +0.76% | ||
| 1 week | -7.24% | ||
| Current month | -0.87% | ||
| 1 month | -17.21% | ||
| 3 months | -1.37% | ||
| 6 months | -39.20% | ||
| Current year | -31.85% |
| 1 week | 7.49 |  | 8.66 |
| 1 month | 7.49 | | 10.87 |
| Current year | 7.03 | | 13.15 |
| 1 year | 6.66 | | 18.63 |
| 3 years | 2.55 | | 18.9 |
| 5 years | 2.55 | | 18.9 |
| 10 years | 2.55 | | 18.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Bell
CTO | Chief Tech/Sci/R&D Officer | - | 05/08/2015 |
Donn Casale
CEO | Chief Executive Officer | 53 | 07/07/2026 |
Sarina Tanimoto
CTO | Chief Tech/Sci/R&D Officer | 57 | 01/09/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Pratik Shah
CHM | Chairman | 56 | 08/11/2022 |
Rajeev Dadoo
BRD | Director/Board Member | 55 | 01/08/2021 |
Saqib Islam
BRD | Director/Board Member | 56 | 01/07/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07-01 | Free | Chief Executive Officer | 898,456 | 0.9048% | ||
| 06-24 | Free | Director | 30,000 | 0.0302% | ||
| 06-24 | Free | Director | 30,000 | 0.0302% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.76% | -7.24% | -55.12% | +22.53% | 788M | |
| +0.58% | +2.06% | +3.90% | +10.40% | 50.73B | |
| -2.22% | -1.25% | +391.53% | +591.38% | 39.73B | |
| -0.54% | +0.39% | +27.67% | -3.89% | 34.69B | |
| -1.36% | +0.35% | +19.34% | +58.83% | 33.21B | |
| +1.21% | -4.58% | +3.00% | +37.03% | 26.76B | |
| -1.81% | -1.48% | - | - | 16.8B | |
| +0.51% | -3.47% | +66.38% | +125.61% | 15.37B | |
| +0.23% | -0.58% | +13.80% | +19.56% | 13.78B | |
| -0.62% | -3.09% | +11.43% | -29.93% | 12.85B | |
| Average | -0.33% | -1.47% | +53.55% | +92.39% | 24.47B | |
| Weighted average by Cap. | -0.48% | -0.25% | +82.27% | +125.78% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 140M 122M 113M 104M 198M 13.34B 201M 1.35B 529M 6.57B 525M 514M 22.59B | 246M 215M 198M 183M 348M 23.44B 353M 2.37B 930M 11.55B 923M 903M 39.7B |
| Net income | -178M -155M -143M -132M -251M -16.95B -256M -1.71B -673M -8.35B -667M -653M -28.71B | -97.73M -85.48M -78.85M -72.82M -138M -9.32B -141M -942M -370M -4.59B -367M -359M -15.78B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | $7.940 | +0.76% | 1,397,535 |
| 09/07/26 | $7.880 | -2.72% | 1,155,796 |
| 08/07/26 | $8.100 | -1.10% | 2,036,599 |
| 07/07/26 | $8.190 | -1.68% | 1,235,305 |
| 06/07/26 | $8.330 | -2.69% | 1,124,311 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SPRY Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
